Roman Sinichkin /
13 April 2016Americas

UK university granted US patent for new cancer drug

The University of Wolverhampton has been granted a US patent for a new bowel cancer drug.

The UK-based university released a statement on Friday, April 8, in which it outlined the details of a patent that has been granted in the US.

According to the university, approximately 16,000 people in the UK die of bowel cancer each year, and there has been evidence to suggest that taking aspirin regularly over long periods of time can stop the onset of the disease.

Doctors in the university’s Research Institute in Healthcare Science have been developing “aspirin-like” molecules over the past eight years and have now identified a possible alternative substance.

A US patent has been granted to the university and it is now looking for collaborative partners to help with testing out ideas.

Christopher Perry, a doctor at the university, said: “The good news seems to be that whilst effective against colorectal cancer cells, the drugs developed so far do not appear to be seriously toxic. The hope is that this will result in reduced side effects.”

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at